A previous study demonstrated that the inhibition of the FMS-like receptor tyrosine kinase-3 (FLT3) up-regulated HDAC8, which promoted p53 acetylation in AML cells with FLT3 internal tandem duplication (ITD) mutations [156]. The gene discussed is FLT3; the disease is acute myeloid leukemia.